author-photo

Junichi Nakazawa

34

Papers

36

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Two cases of liver cirrhosis with hyperammonemic encephalopathy caused by urease-producing bacteria in the urinary tract.

2021 Clinical Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study).

2021 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of factors affecting progression-free survival of first-line chemotherapy in older patients with advanced gastrointestinal cancer.

2021 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Gemcitabine Plus Nab-Paclitaxel Versus FOLFIRINOX in Locally Advanced, Unresectable Pancreatic Cancer: A Multicenter Observational Study (NAPOLEON Study).

2021 Pancreas
Show All
- Source
- Cite
- Save
Citations (0)
SO-1 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study)

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Scoring model with serum albumin and CA19-9 in advanced pancreatic cancer in second-line treatment: Results from the NAPOLEON study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Nomogram for Patients With Unresectable Pancreatic Cancer Treated With Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX: Real-world Results From a Multicenter Retrospective Study (NAPOLEON study).

2020
Show All
- Source
- Cite
- Save
Citations (0)
PD-5 Impact of biliary drainage for unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel: Results from the NAPOLEON study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-88 A multicenter analysis of the correlation between overall survival and progression-free survival and the number of chemotherapeutic key drugs used in patients with advanced/unresectable pancreatic cancer: Results from the NAPOLEON study

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-065A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (4)